Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PRELP was expressed (RT-PCR) in all CLL patients (30/30), as well as in some patients with mantle cell lymphoma (3/5), but not in healthy donor leukocytes (0/20) or tumor samples from other hematological malignancies (0/35).
|
23826326 |
2013 |
Mantle cell lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PRELP was expressed (RT-PCR) in all CLL patients (30/30), as well as in some patients with mantle cell lymphoma (3/5), but not in healthy donor leukocytes (0/20) or tumor samples from other hematological malignancies (0/35).
|
23826326 |
2013 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
PRELP was expressed (RT-PCR) in all CLL patients (30/30), as well as in some patients with mantle cell lymphoma (3/5), but not in healthy donor leukocytes (0/20) or tumor samples from other hematological malignancies (0/35).
|
23826326 |
2013 |
Hematologic Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
PRELP was also detected in CLL cell-lines (4/4) but not in cell-lines from other hematological tumors (0/9).
|
23826326 |
2013 |
Chronic Lymphocytic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
PRELP protein was detected in all CLL samples but not in normal leukocytes.
|
23826326 |
2013 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A simple linear formula derived from gene expression values of four genes (GFAP, PTPRZ1, GPM6B, and PRELP) measured from cDNA microarrays (n = 35) have distinguished glioblastoma and meningioma cases in a previous study.
|
20235875 |
2010 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A simple linear formula derived from gene expression values of four genes (GFAP, PTPRZ1, GPM6B, and PRELP) measured from cDNA microarrays (n = 35) have distinguished glioblastoma and meningioma cases in a previous study.
|
20235875 |
2010 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A simple linear formula derived from gene expression values of four genes (GFAP, PTPRZ1, GPM6B, and PRELP) measured from cDNA microarrays (n = 35) have distinguished glioblastoma and meningioma cases in a previous study.
|
20235875 |
2010 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
A simple linear formula derived from gene expression values of four genes (GFAP, PTPRZ1, GPM6B, and PRELP) measured from cDNA microarrays (n = 35) have distinguished glioblastoma and meningioma cases in a previous study.
|
20235875 |
2010 |
Meningioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A simple linear formula derived from gene expression values of four genes (GFAP, PTPRZ1, GPM6B, and PRELP) measured from cDNA microarrays (n = 35) have distinguished glioblastoma and meningioma cases in a previous study.
|
20235875 |
2010 |
Adult Meningioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A simple linear formula derived from gene expression values of four genes (GFAP, PTPRZ1, GPM6B, and PRELP) measured from cDNA microarrays (n = 35) have distinguished glioblastoma and meningioma cases in a previous study.
|
20235875 |
2010 |
Meningioma, benign, no ICD-O subtype
|
0.010 |
Biomarker
|
disease |
BEFREE |
A simple linear formula derived from gene expression values of four genes (GFAP, PTPRZ1, GPM6B, and PRELP) measured from cDNA microarrays (n = 35) have distinguished glioblastoma and meningioma cases in a previous study.
|
20235875 |
2010 |
Severe myopia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Analysis of 85 English and 40 Finnish subjects with high myopia (refractive error of -6 diopters [D] or greater) resulted in 23 sequence variations in four SLRP genes, LUM, FMOD, PRELP, and OPTC.
|
17117407 |
2007 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
0.020 |
Biomarker
|
disease |
BEFREE |
Immunohistochemistry analysis using an independent cohort of 145 PDAC confirmed that the higher abundance of ribosomal protein S8 (RPS8) and prolargin (PRELP) were correlated with STS and VLTS, respectively.
|
25347153 |
2015 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Moreover, PRELP reduces <i>Moraxella</i> adherence to and invasion of human lung epithelial A549 cells.
|
28148731 |
2017 |
Degenerative polyarthritis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
RA vs OA gel comparison showed elevated prolargin levels in RA with biglycan levels remaining unaltered.
|
29402456 |
2018 |
Progeria
|
0.010 |
Biomarker
|
disease |
BEFREE |
The appearance of PRELP sometime after the third month of the birth, coincides with the appearance of HGP symptoms.
|
12437997 |
2003 |
Psoriasis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of PRELP, whose products are secreted in the extracellular space, in the psoriasis group was 1.351684 folds that of the control.
|
30198149 |
2019 |
Endometriosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of the ID2, PRELP and SMOC2 genes was compared between the endometrium of women without endometriosis in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.
|
28678915 |
2017 |
Endometrioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.
|
28678915 |
2017 |
Chocolate cyst of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.
|
28678915 |
2017 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
0.020 |
Biomarker
|
disease |
BEFREE |
The Kaplan-Meier survival analysis revealed a significant correlation of protein abundance of PRELP with postoperative survival of patients with PDAC.
|
24459066 |
2014 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The results from our study suggested that PRELP, LGALS1 and RPS8 might be significant prognostic factors, and RPS8 and LGALS1 could be potential therapeutic targets to improve pancreatic cancer survival if further validated.
|
25347153 |
2015 |
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
The results from our study suggested that PRELP, LGALS1 and RPS8 might be significant prognostic factors, and RPS8 and LGALS1 could be potential therapeutic targets to improve pancreatic cancer survival if further validated.
|
25347153 |
2015 |